Long term prescriptions for anti-appetite drugs still unchanged.

Published: 2005-12-06 06:59:00

Updated: 2005-12-06 06:59:00

Despite the KFDA's tough restriction policy, more than 4 weeks of long term prescriptions of the anti-appetite drugs still remained uncontrolled, giving many confusion to the retail pharmacy sectors.

A pharmacy community said that although the KFDA circulated letters to medical institutions...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK